Markedly increased Rho-kinase activity in circulating leukocytes in patients with chronic heart failure

American Heart Journal

Volumn 161, Issue 5, 2011, Pages 931-937

  Ocaranza, María Paz ^a   Gabrielli, Luigi ^a   Mora, Italo ^a   Garcia, Lorena ^b,c,d   McNab, Paul ^a   Godoy, Iván ^a   Braun, Sandra ^a   Córdova, Samuel ^a   Castro, Pablo ^a   Novoa, Ulises ^a   Chiong, Mario ^b,c,d   Lavandero, Sergio ^b,c,d,e   Jalil, Jorge E ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

^c Centro FONDAP Estudios Moleculares de la Celula   (Chile)

^d UNIVERSITY OF CHILE   (Chile)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; MYOSIN LIGHT CHAIN PHOSPHATASE; RHO KINASE;

ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE; HEART VENTRICLE REMODELING; HEART VENTRICLE SIZE; HUMAN; LEUKOCYTE; MALE; PRIORITY JOURNAL; SYSTOLIC DYSFUNCTION;

BLOTTING, WESTERN; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; MYOSIN-LIGHT-CHAIN PHOSPHATASE; PHOSPHORYLATION; RHO-ASSOCIATED KINASES; SEVERITY OF ILLNESS INDEX; VENTRICULAR FUNCTION, LEFT;

EID: 79955919204     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2011.01.024     Document Type: Article

References (39)

1. J.E. Jalil, S. Lavandero, and M. Chiong Rho/Rho-kinase signal transduction pathway in cardiovascular disease and cardiovascular remodeling Rev Esp Cardiol 58 2005 951 961 (Pubitemid 41419170)
2. H. Shimokawa, and A. Takeshita Rho-kinase is an important therapeutic target in cardiovascular medicine Arterioscler Thromb Vasc Biol 25 2005 1767 1775 (Pubitemid 41243442)
3. H. Shimokawa, and M. Rashid Development of Rho-kinase inhibitors for cardiovascular medicine Trends in Pharm Sciences 28 2007 296 302 (Pubitemid 46818464)
4. S. Mita, N. Kobayashi, and K. Yoshida Cardioprotective mechanisms of Rho-kinase inhibition associated with eNOS and oxydative stress-LOX-1 pathway in Dahl salt-sensitive hypertensive rats J Hypertens 23 2005 87 96 (Pubitemid 40128985)
5. K. Ishimaru, H. Ueno, and S. Kagitani Fasudil attenuates myocardial fibrosis in association with inhibition of monocyte/macrophage infiltration in the heart of DOCA/salt hypertensive rats J Cardiovasc Pharmacol 50 2007 187 194 (Pubitemid 47267744)
6. T. Hattori, H. Shimokawa, and M. Higashi Long-term inhibition of Rho-kinase suppresses left ventricular remodeling after myocardial infarction in mice Circulation 109 2004 2234 2239 (Pubitemid 38625402)
7. A. Nohria, A. Prsic, and P.Y. Liu Statins inhibit Rho kinase activity in patients with atherosclerosis Atherosclerosis 205 2009 517 521
8. R. Rawlings, A. Nohria, and P.Y. Liu Comparison of effects of rosuvastatin (10 mg) versus atorvastatin (40 mg) on rho kinase activity in caucasian men with a previous atherosclerotic event Am J Cardiol 103 2009 437 441
9. S.T. Reeves, K.E. Glas, and H. Eltzschig Guidelines for performing a comprehensive epicardial echocardiography examination: recommendations of the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists J Am Soc Echocardiogr 20 2007 427 437 (Pubitemid 46497636)
10. R.M. Lang, M. Bierig, and R.B. Devereux Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463 (Pubitemid 41821197)
11. R.B. Devereux, D.R. Alonso, and E.M. Lutas Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings Am J Cardiol 57 1986 450 458 (Pubitemid 16119719)
12. V. Palmieri, B. Dahlöf, and V. DeQuattro Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study. Prospective Randomized Study Evaluating Regression of Ventricular Enlargement J Am Coll Cardiol 34 1999 1625 1632 (Pubitemid 29528680)
13. Asmar R., Topouchian J., and Pannier B. Pulse wave velocity as endpoint in large-scale intervention trial. The Complior study. Scientific, Quality Control, Coordination and Investigation Committees of the Complior Study J Hypertens 19 2001 813 818 (Pubitemid 32289562)
14. O. Pérez, P. Castro, and G. Díaz-Araya Persistence of oxidative stress after heart transplantation: a comparative study of patients with heart transplant versus chronic stable heart failure Rev Esp Cardiol 55 2002 831 837
15. P.Y. Liu, J.H. Chen, and L.J. Lin Increased Rho-kinase activity in a Taiwanese population with metabolic syndrome J Am Coll Cardiol 49 2007 1619 1624
16. F. Li, W. Xia, and S. Yuan Acute inhibition of Rho-kinase attenuates pulmonary hypertension in patients with congenital heart disease Pediatr Cardiol 30 2009 363 366
17. K. Ishikura, N. Yamada, and M. Ito Beneficial acute effects of rho-kinase inhibitor in patients with pulmonary arterial hypertension Circ J 70 2006 174 178 (Pubitemid 43170128)
18. Y. Fukumoto, T. Matoba, and A. Ito Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension Heart 91 2005 391 392 (Pubitemid 40299237)
19. Z. Do e, Y. Fukumoto, and A. Takaki Evidence for Rho-kinase activation in patients with pulmonary arterial hypertension Circ J 73 2009 1731 1739
20. A. Masumoto, Y. Hirooka, and H. Shimokawa Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans Hypertension 38 2001 1307 1310 (Pubitemid 34033407)
21. A. Nohria, M.E. Grunert, and Y. Rikitake Rho-kinase inhibition improves endothelial function in human subjects with coronary artery disease Circ Res 99 2006 1426 1432 (Pubitemid 44949679)
22. T. Kishi, Y. Hirooka, and A. Masumoto Rho-kinase inhibitor improves increased vascular resistance and impaired vasodilation of the forearm in patients with heart failure Circulation 111 2005 2741 2747 (Pubitemid 40791544)
23. R.M. van de Wal, H.W. Plokker, and D.J. Lok Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition Int J Cardiol 106 2006 367 372 (Pubitemid 41766640)
24. A.D. Struthers The clinical implications of aldosterone escape in congestive heart failure Eur J Heart Fail 6 2004 539 545 (Pubitemid 39070505)
25. M. Cicoira, L. Zanolla, and L. Franceschini Relation of aldosterone "escape" despite angiotensin-converting enzyme inhibitor administration to impaired exercise capacity in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy Am J Cardiol 89 2002 403 407 (Pubitemid 34142514)
26. J.C. Xiu, P. Wu, and J.P. Xu Effects of long-term enalapril and losartan therapy of heart failure on cardiovascular aldosterone J Endocrinol Invest 25 2002 463 468 (Pubitemid 34516595)
27. C. Oliveri, M.P. Ocaranza, and X. Campos Angiotensin I-converting enzyme modulates neutral endopeptidase activity in the rat Hypertension 38 3 Pt 2 2001 650 654
28. P. Rivera, M.P. Ocaranza, and S. Lavandero Rho-kinase activation and gene expression related to vascular remodeling in normotensive rats with high angiotensin I converting enzyme levels Hypertension 50 2007 792 798 (Pubitemid 47442747)
29. J. Jalil, R. Corbalán, and G. Chamorro Adrenergic response to dynamic exercise in healthy subjects and in patients with chronic cardiac insufficiency Rev Med Chil 116 1988 215 221
30. S. Fukui, Y. Fukumoto, and J. Suzuki Long-term inhibition of Rho-kinase ameliorates diastolic heart failure in hypertensive rats J Cardiovasc Pharmacol 51 2008 317 326 (Pubitemid 351450612)
31. A. Phrommintikul, L. Tran, and A. Kompa Effects of a Rho-kinase inhibitor on pressure overload induced cardiac hypertrophy and associated diastolic dysfunction Am J Physiol Heart Circ Physiol 294 2008 H1804 H1814
32. J. Shi, Y.W. Zhang, and L.J. Summers Disruption of ROCK1 gene attenuates cardiac dilation and improves contractile function in pathological cardiac hypertrophy J Mol Cell Cardiol 44 2008 551 560
33. M. Kobayashi, Y. Tanoue, and M. Eto A Rho-kinase inhibitor improves cardiac function after 24-hour heart preservation J Thorac Cardiovasc Surg 136 2008 1586 1592
34. D.P. Del Re, S. Miyamoto, and J.H. Brown RhoA/Rho-kinase up-regulate Bax to activate a mitochondrial death pathway and induce cardiomyocyte apoptosis J Biol Chem 282 2007 8069 8078 (Pubitemid 47093605)
35. (2+) sensitivity of contraction and impairs cardiac function Circ J 74 2010 120 128
36. M.R. Bristow, P. Larrabee, and B. Muller-Beckmann Effects of carvedilol on adrenergic receptor pharmacology in human ventricular myocardium and lymphocytes Clin Investig 70 1992 S105 S113
37. L.S. Sun, C.B. Pantuck, and J.J. Morelli Perioperative lymphocyte adenylyl cyclase function in the pediatric cardiac surgical patient Crit Care Med 24 1996 1654 1659 (Pubitemid 26347377)
38. N. Dzimiri, and A. Moorji Relationship between alterations in lymphocyte and myocardial beta- adrenoceptor density in patients with left heart valvular disease Clin Exp Pharmacol Physiol 23 1996 498 502
39. G. Iaccarino, E. Barbato, and E. Cipolletta Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure Eur Heart J 26 2005 1752 1758 (Pubitemid 41219848)